Cite
HARVARD Citation
Pratz, K. et al. (2022). Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine. Journal of clinical oncology. 40 (8), pp. 855-865. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pratz, K. et al. (2022). Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine. Journal of clinical oncology. 40 (8), pp. 855-865. [Online].